Showing results (191-200 of 222) with videos related to
Sort By:
Pageof 23
Acta Neuropsychiatrica|June 7, 2019
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trialsOle Köhler-Forsberg, Louisa G Sylvia, Charles L Bowden, et al.JAMA Network Open|June 30, 2026
Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric DisordersDavid T Liebers, Tianshe He, Rebecca A Betensky, et al.Psychiatry Research|September 9, 2021
Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-responseOle Köhler-Forsberg, Kirstine H Sloth, Louisa G Sylvia, et al.Plos One|December 3, 2010
Microstructural abnormalities in subcortical reward circuitry of subjects with major depressive disorderAnne J Blood, Dan V Iosifescu, Nikos Makris, et al.Molecular Psychiatry|January 9, 2019
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.Journal of Affective Disorders|September 11, 2025
Adverse childhood experiences and cardiometabolic risk factors in people with bipolar disorderAlyna Turner, Maya Kuperberg, Hugh McGovern, et al.Neuron|October 23, 2008
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?Nikos Makris, Gregory P Gasic, David N Kennedy, et al.Molecular Psychiatry|October 5, 2018
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.Depression and Anxiety|June 30, 2020
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trialsOle Köhler-Forsberg, Louisa G Sylvia, Vicki Fung, et al.World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 10, 2021
Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trialAbraham Zangen, Hagar Moshe, Diana Martinez, et al.Pageof 23